Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Chubb
McKinsey
Johnson and Johnson
Harvard Business School

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent Applications for naltrexone

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patent Applications for naltrexone

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
➤ Sign Up ➤ Sign Up N-CHLOROPHENYLCARBAMATE AND N-CHLOROPHENYLTHIOCARBAMATE COMPOSITIONS 2000-12-22 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2012-03-05
➤ Sign Up ➤ Sign Up METHOD FOR PREPARING OXYCODONE 2001-02-26 Patented Case 2002-05-24
➤ Sign Up ➤ Sign Up CELL DELIVERY COMPOSITIONS 1999-02-17 Patented Case 2004-01-29
➤ Sign Up ➤ Sign Up METHOD OF SIMULTANEOUSLY ENHANCING ANALGESIC POTENCY AND ATTENUATING ADVERSE SIDE EFFECTS CAUSED BY TRAMADOL AND OTHER BIMODALLY-ACTING OPIOID AGONISTS 1999-05-06 Abandoned -- Failure to Respond to an Office Action 2002-05-22
➤ Sign Up ➤ Sign Up Retroviral protease inhibiting compounds 2001-02-06 Abandoned -- Failure to Respond to an Office Action 2002-10-10
➤ Sign Up ➤ Sign Up METHOD AND COMPOSITION FOR TREATING IRRITABLE BOWEL SYNDROME USING LOW DOSES OF OPIOID RECEPTOR ANTAGONISTS 2001-01-04 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-06-28
➤ Sign Up ➤ Sign Up DESMETHYLSELEGILINE ENANTIOMERS AND THEIR USE TO TREAT DRUG WITHDRAWAL SYMPTOMS 2001-03-13 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2011-06-13
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Colorcon
Fish and Richardson
Boehringer Ingelheim
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.